Search

everythinglearnresearchcommunity

for

Search:↓

A systematic approach is crucial for managing hair loss in women.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Clomipramine alone does not reduce overgrooming in cats with psychogenic alopecia.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Topical minoxidil not effective for erectile dysfunction treatment.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Finasteride use may cause sexual dysfunction; more research needed.

Transdermal fluoxetine is less effective in cats, clomipramine may help with feline alopecia, younger dogs often start fights, dietary changes can reduce cribbing in horses, negative aggression tests in shelter dogs predict good behavior, many older cats show cognitive issues, and fluoxetine or paroxetine can improve canine anxiety.

Androgens might not be the only major factor in hair loss; other elements could also be important.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Patients with non-scarring hair loss often have emotional disorders.

A man had temporary hair loss after a spinal cord injury, with some permanent thinning remaining.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.